openPR Logo
Press release

China Monoclonal Antibody Market by Targets (PD-1, CD20, HER2, VEGF, EGFR, TNF-?) Research Report representing a CAGR of 42.6% from 2017 to 2022

05-16-2019 11:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Hub

China Monoclonal Antibody Market by Targets (PD-1, CD20, HER2,

It has been observed that, the global market for China Monoclonal Antibody Market would be experiencing steady growth marked in million US$ by 2025. Such advancements can be attributed to the efforts put in by prime manufacturers operating in the global China Monoclonal Antibody Market during the period 2018-2025. All such statistics and figures are carefully enclosed in a recently uploaded research report titled “China Monoclonal Antibody Market by Targets (PD-1, CD20, HER2, VEGF, EGFR, TNF-?) Research Report”, 2018-2025, onto its broad online database. Readers are enlightened about different aspects associated to the global China Monoclonal Antibody Market which covers growth rate, revenue share, geographical market share, sales channel and Porter’s Five Forces analysis

Request Sample Copy of the Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2339972

China’s oncology drug market has grown rapidly in recent years. Revenue of the oncology drugs in China grew from RMB83.4 billion in 2013 to RMB139.4 billion in 2017, representing a CAGR of 13.7%. It is expected to further grow to RMB262.1 billion in 2022 at a CAGR of 13.5% from 2017, and to RMB654.1 billion in 2030 at a CAGR of 12.1% from 2022.

While the majority of the top ten oncology drugs globally in 2017 are either molecularly targeted drugs or immuno-oncology drugs, seven out of the top ten oncology drugs in China are chemotherapy drugs and only three are molecularly targeted drugs. This difference between the global market and the China market suggests significant potential for molecularly targeted drug and immuno-oncology drug market growth in China. Three drugs among the top10 oncology drugs globally were recently approved in China in 2018, indicating China is at its early stage of its paradigm shift to molecularly targeted drugs and immuno-oncology drugs.

Among all types of cancers, lung cancer, liver cancer, stomach cancer, colorectal cancer and breast cancer are the top five cancer types in China by incidence rate, accounting for more than 50% of the annual incidence in the aggregate. The incidences of lung cancer, colorectal cancer and esophageal cancer are expected to grow at higher CAGRs than the others. Such higher CAGR for lung cancer is attributed to the growing smoking population and air pollution. As for colorectal and esophageal cancer, the higher CAGRs are attributable mainly to increasingly prevalence of unhealthy dietary habits.

mAbs (including fusion proteins) only accounted for 5.4% of China’s biologics market in 2017, while globally the figure was 43.2% in the same year, representing a sizable market potential. With the inclusion of more mAbs into the NRDL, sales revenue of China’s mAbs market is expected to grow to RMB69.6 billion in 2022, representing a CAGR of 42.6% from 2017 to 2022, which will outpace the growth of China’s overall biologics market. The diagram below illustrates the size of China’s mAb market from 2013 to 2017 and the estimated market size from 2018 to 2022.

In addition to monotherapies, PD-1/L1 inhibitors have shown significant potential in combined therapies. PD-1/PD-L1 inhibitors market is still at an early stage of development but has strong growth potentials. The market size of PD-1 and PD-L1 inhibitors together is estimated to grow to RMB37.4 billion in 2022, representing a CAGR of 534.4% from 2018 to 2022, and further increase to RMB98.4 billion in 2030, representing a CAGR of 12.8% from 2022 to 2030.

In December 2018, the State Drug Administration ( NMPA ) announced that it would conditionally approve the listing of the first domestically produced PD-1 monoclonal antibody, tripril monoclonal antibody injection. Tripril monoclonal antibody was developed by Suzhou Zhonghe Biomedical Co., Ltd. (A subsidiary of Shanghai Junshi Biosciences Co., Ltd.) to treat local progression or metastatic melanoma after previous standard treatment failure.

Currently, there are 6 PD-1/PD-L1 listed in the world, of which 2 PD-1 drugs, namely Opdivo of Bristol - Myers Squibb and Keytruda of Mercadon, have been approved for listing in China in 2018. 

Among the domestic R&D companies for PD-1, Innovent Biologics, Inc., Hengrui Medicine and BeiGene, Ltd. have also submitted drug listing applications, but the application indications are all classic Hodgkin lymphoma, and there is no direct competitive relationship with the currently approved indications of Opdivo and Keytruda.

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/china-monoclonal-antibody-market-by-targets-pd1cd20her2vegfegfrtnf-research-report-20182025-report.html

Table of Content

Policy Snapshot

1.1 Snapshot of Policies
1.2 Basic Data Requirements for Reporting and Listing of Anti - PD-1/PD-L1 Monoclonal Antibody
1.3 Opinions on Reform of the Drug and Medical Device Review and Approval
1.4 The State Organized Pilot Program for Centralized Drug Procurement
1.4.1 Characteristics and Significance of Drugs Procurement with Target Quantity
1.4.2 Impact on Foreign Enterprises and Local Enterprises
1.4.3 Development Trend of Drugs Procurement with Target Quantity

Overview of Chinese Monoclonal Antibody Market

2.1 China’s Oncology Drug Market
2.2 Market Outlook of China’s Monoclonal Antibody

Chinese Monoclonal Antibody Market by Target Species

3.1 PD-1/PD-L1
3.1.1 Indication and usage
3.1.2 Primary drug resistance and acquired drug-resistance of PD-1/PD-L1 makes combo therapy a inevitable trend
3.1.3 PD-L1 expression quantity, MSI, TMB-core predictive markers of most immunotherapies
3.1.4 Immune checkpoint inhibitors combo and oncolytic virus combo-the new R&D direction
3.1.5 Market cap outlook of PD-1/PD-L1 drugs
3.1.6 Competitive landscape
3.2 CD20
3.2.1 First generation CD20- Rituximab
3.2.2 Second generation CD20- Ofatumumab & Ocrevus
3.2.3 Third generation CD20- Obinutuzumab: FC portions glycosylation modification, better therapeutic effect on lymphoma
3.2.4 Market cap outlook of CD20 drugs
3.3 HER2
3.3.1 Trastuzumab-initial therapy for HER2 positive breast cancer and gastric cancer
3.3.2 Continuous emerging of new HER2 target point drugs
3.3.3 Market cap outlook of HER2 drugs
3.4 VEGF
3.4.1 New direction of anti VEGF - multi target inhibiting of angiogenesis and immunotherapy combined therapy
3.4.2 PDGF – significant target for accessory angiogenesis
3.4.3 Typical anti VEGF drug – Bevacizumab
3.4.4 Applications of anti VEGF drugs in ophthalmology
3.4.5 Market cap outlook of VEGF drugs
3.5 EGFR
3.5.1 Major biological target for colorectal cancer and NSCLC, expanding therapy for other tumours
3.5.2 EGFR small molecule targeting - breakthrough treatments of positive NSCLC, fierce competition of TKIs
3.5.3 Market cap outlook of EGFR monoclonal antibody
3.5.4 Market cap outlook of EGFR TKI

Continued………@#

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research   and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us         

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)

Email: press@marketresearchhub.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release China Monoclonal Antibody Market by Targets (PD-1, CD20, HER2, VEGF, EGFR, TNF-?) Research Report representing a CAGR of 42.6% from 2017 to 2022 here

News-ID: 1741712 • Views:

More Releases from Market Research Hub

Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, Leading Players : DEWALT, Shark,Benchmark Abrasives,Bosch,Hot Max Up to 2025
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, Stiplastics S.A.S, Argo S.A, Gramb GmbH Kunststoffverarbeitung, Origin Pharma Packaging, Eastman Chemical Company, Yuyao Liantong Plastic & Mould Co., Ltd
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstock, MingYue, Conant, Wanxin, CHEMI, Nikon
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the

All 5 Releases


More Releases for China

Forehead Thermometer Market Analysis (2019- 2025)| Microlife (China), Radiant (C …
This research study is one of the most detailed and accurate ones that solely focus on the global Forehead Thermometer market. It sheds light on critical factors that impact the growth of the global Forehead Thermometer market on several fronts. Market participants can use the report to gain a sound understanding of the competitive landscape and strategies adopted by leading players of the global Forehead Thermometer market. The authors of
Analysis of the Global And China Handheld Transceiver Market-Top players BAOFENG …
The Global And China Handheld Transceiver Market is a professional report which provides thorough knowledge along with complete information perta¬ining to the Handheld Transceiver industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc. Key Regions First-tier Cities • Beijing • Shanghai • Guangzhou • Shenzhen Free Sample PDF Copy of Handheld Transceiver Market research report @ https://www.qyresearchgroups.com/request-sample/453291 Report Includes:- This report focus Chinese market, it covers details as following: Key
Analysis of the Global And China Calculator Market-Top players Aurora(Taiwan, Ch …
The Global And China Calculator Market is a professional report which provides thorough knowledge along with complete information perta¬ining to the Calculator industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc. Key Regions First-tier Cities • Beijing • Shanghai • Guangzhou • Shenzhen Free Sample PDF Copy of Calculator Market research report @ https://www.qyresearchgroups.com/request-sample/453273 Report Includes:- This report focus Chinese market, it covers details players regions product type and
Analysis of the Global And China Activity Tracker Market-Top MI(China), Huawei(C …
The Global And China Activity Tracker Market is a professional report which provides thorough knowledge along with complete information perta¬ining to the Activity Tracker industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc. Key Regions First-tier Cities • Beijing • Shanghai • Guangzhou • Shenzhen Free Sample PDF Copy of Activity Tracker Market research report @ https://www.qyresearchgroups.com/request-sample/453264 Report Includes:- This report focus Chinese market, it covers details players regions
Analysis of the Global And China Money Counter Market-Top players Deli(China) ,W …
The Global And China Money Counter Market is a professional report which provides thorough knowledge along with complete information perta¬ining to the Money Counter industry propos classifications, definitions, applications, industry chain summary, industry policies in addition to plans, product specifications, manufacturing processes, cost structures, etc. Key Regions First-tier Cities • Beijing • Shanghai • Guangzhou • Shenzhen Free Sample PDF Copy of Money Counter Market research report @ https://www.qyresearchgroups.com/request-sample/453304 Report Includes:- This report focus Chinese market, it covers details as following: Key
Global Color Steel Tile Market 2017 - South China, East China, Southwest China, …
Color Steel Tile Market Research Report A market study based on the " Color Steel Tile Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Color Steel Tile Market 2017’. The research report analyses the historical as well as present performance of the worldwide Color Steel Tile industry, and makes predictions on the future status of Color Steel Tile market on the basis